
Reset all filters
01 1Eli Lilly And Company Indianapolis US
Reset all filters
01 1Zinc insulin crystals, Product numbers QA241B, ID4028
Reset all filters
01 1U.S.A
Reset all filters
01 1Withdrawn by Holder
Zinc Insulin Crystals, Product Numbers QA241B, I...
Certificate Number : R0-CEP 2000-313 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2005-02-28
Type : TSE
Substance Number :
85
PharmaCompass offers a list of Caninsulin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Caninsulin manufacturer or Caninsulin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Caninsulin manufacturer or Caninsulin supplier.
PharmaCompass also assists you with knowing the Caninsulin API Price utilized in the formulation of products. Caninsulin API Price is not always fixed or binding as the Caninsulin Price is obtained through a variety of data sources. The Caninsulin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NOVOLIN N manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NOVOLIN N, including repackagers and relabelers. The FDA regulates NOVOLIN N manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NOVOLIN N API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A NOVOLIN N supplier is an individual or a company that provides NOVOLIN N active pharmaceutical ingredient (API) or NOVOLIN N finished formulations upon request. The NOVOLIN N suppliers may include NOVOLIN N API manufacturers, exporters, distributors and traders.
click here to find a list of NOVOLIN N suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NOVOLIN N CEP of the European Pharmacopoeia monograph is often referred to as a NOVOLIN N Certificate of Suitability (COS). The purpose of a NOVOLIN N CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of NOVOLIN N EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of NOVOLIN N to their clients by showing that a NOVOLIN N CEP has been issued for it. The manufacturer submits a NOVOLIN N CEP (COS) as part of the market authorization procedure, and it takes on the role of a NOVOLIN N CEP holder for the record. Additionally, the data presented in the NOVOLIN N CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the NOVOLIN N DMF.
A NOVOLIN N CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. NOVOLIN N CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of NOVOLIN N suppliers with CEP (COS) on PharmaCompass.